These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16946390)

  • 1. Diabetes management in the USA and England: comparative analysis of national surveys.
    Mainous AG; Diaz VA; Saxena S; Baker R; Everett CJ; Koopman RJ; Majeed A
    J R Soc Med; 2006 Sep; 99(9):463-9. PubMed ID: 16946390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries.
    Landon BE; Zaslavsky AM; Souza J; Ayanian JZ
    J Gen Intern Med; 2018 Apr; 33(4):471-480. PubMed ID: 29427177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.
    Pelletier EM; Smith PJ; Boye KS; Misurski DA; Tunis SL; Minshall ME
    Appl Health Econ Health Policy; 2008; 6(2-3):103-12. PubMed ID: 19231904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of use and expenses associated with mail-service pharmacy in adults with diabetes.
    Wu J; Davis-Ajami ML; Noxon V
    J Am Pharm Assoc (2003); 2015; 55(1):41-51. PubMed ID: 25539092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes costs rise, but so does adherence.
    Manag Care; 2005 Apr; 14(4):54. PubMed ID: 15898213
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey.
    Le P; Chaitoff A; Misra-Hebert AD; Ye W; Herman WH; Rothberg MB
    Diabetes Care; 2020 Jun; 43(6):1227-1233. PubMed ID: 32234720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes care in sub-Saharan Africa].
    Labie D
    Med Sci (Paris); 2007 Mar; 23(3):320-2. PubMed ID: 17349296
    [No Abstract]   [Full Text] [Related]  

  • 9. Part D coverage gap and adherence to diabetes medications.
    Gu Q; Zeng F; Patel BV; Tripoli LC
    Am J Manag Care; 2010; 16(12):911-8. PubMed ID: 21348561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
    CDC Diabetes Cost-effectiveness Group
    JAMA; 2002 May; 287(19):2542-51. PubMed ID: 12020335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of insulin patents and market exclusivities in the USA.
    Luo J; Kesselheim AS
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):835-7. PubMed ID: 26453281
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings.
    Stuart BC; Simoni-Wastila L; Zhao L; Lloyd JT; Doshi JA
    Diabetes Care; 2009 Apr; 32(4):647-9. PubMed ID: 19171724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying factors that affect patients' willingness to pay for inhaled insulin.
    Pinto SL; Holiday-Goodman M; Black CD; Lesch D
    Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and influences on use of antidiabetic drugs in England, 1992-2003.
    Walley T; Hughes D; Kendall H
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):769-73. PubMed ID: 15768446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and control of diabetes mellitus in the United States National Health and Nutrition Examination Survey, 1999-2002.
    Ong KL; Cheung BM; Man YB; Wong LY; Wat NM; Tan KC; Lam KS
    J Cardiometab Syndr; 2006; 1(5):301-7. PubMed ID: 17679791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hypertension healthcare outcomes among older people in the USA and England.
    Marshall A; Nazroo J; Feeney K; Lee J; Vanhoutte B; Pendleton N
    J Epidemiol Community Health; 2016 Mar; 70(3):264-70. PubMed ID: 26598759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India.
    Misra A; Mukherjee R; Luthra A; Singh P
    Diabetes Technol Ther; 2017 Dec; 19(12):693-698. PubMed ID: 29090974
    [No Abstract]   [Full Text] [Related]  

  • 20. The market in diabetes.
    Hauber A; Gale EA
    Diabetologia; 2006 Feb; 49(2):247-52. PubMed ID: 16416145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.